International Biotechnology and Pharmaceutical Industry Forum

December 07

Add to My Calendar Time: 08:30 AM - 06:30 PM

December 07, 2018 09:00 AM December 07, 2018 06:30 PM Hyderabad, India International Biotechnology and Pharmaceutical Industry Forum Hyderabad, India Clyto Access true MM/DD/YYYY

Sessions - Biopharma 2018

Topics of interest for submission include, but are not limited to:

Main sessions:

  1. Biopharmaceutical Drug Design and Development
  2. Nanoparticles-An Innovative Drug Delivery System
  3. Biopharmaceutical Informatics
  4. Clinical Trials on Biopharmaceutical Products
  5. Drug pricing
  6. Gene therapy
  7. Biosimilars and Biologic Drugs
  8. Regulatory Affairs
  9. Biopharmaceutical Products
  10. Cellular and Gene Therapy
  11. Pharmacovigilance
  12. Clinical Trials
  13. Biopharma Insights
  14. Agricultural Biotechnology
  15. Plant Biotechnology
  16. Environment Biotechnology
  17. Food Processing safety and Technology
  18. Animal Biotechnology
  19. Pharmaceutical Biotechnology
  20. Cell science and Cell Biology
  21. Biomedical Engineering
  22. Bioinformatics and System Biology
  23. Industrial Biotechnology
  24. New Tools, products and design in Bioscience
  25. Biopharmaceutical Drug manufacturing
  26. Biotechnology and Pharma applications


Abstract submission deadline (1st round)
15 October 2018

Notification of acceptance or rejection of abstract
03-10 working days from the date of submission

Final presentation should be submitted

15 days before the conference date

Early bird registration

20 October 2018


The global biotechnology market size was valued at USD 270.5 billion in 2013 and is expected to grow at a CAGR of 12.3% owing to the increasing demand for diagnostics and therapeutic solutions such as recombinant technology, red biotechnology, and DNA sequencing. The increasing prevalence of diseases such as cancer, hepatitis B, and other orphan disorders is expected to serve as a high impact rendering driver for this industry over the forecast period. Rising government initiatives owing to high significance towards growth of the economy are expected to boost the biotechnology market growth over the forecast period.

Furthermore, the presence of organizations, such as the DBT, together with other government-funded institutions such as the NBTB and other autonomous organizations representing the biotechnology industry promotes funding to support R&D and product development exercises pertaining to the field and are expected to drive growth from 2013 to 2020.